Metagenomi, Inc. Common Stock MGX
MGX
Metagenomi, Inc. Common Stock DTIL
Precision BioSciences, Inc. ATYR
aTyr Pharma, Inc. ADVM
Adverum Biotechnologies, Inc. ARTV
Artiva Biotherapeutics, Inc. STRO
Sutro Biopharma, Inc. QNCX
Quince Therapeutics, Inc. IFRX
InflaRx N.V. KLRS
Kalaris Therapeutics Inc CNTB
Connect Biopharma Holdings Limited
Metagenomi, Inc. Common Stock DTIL
Precision BioSciences, Inc. ATYR
aTyr Pharma, Inc. ADVM
Adverum Biotechnologies, Inc. ARTV
Artiva Biotherapeutics, Inc. STRO
Sutro Biopharma, Inc. QNCX
Quince Therapeutics, Inc. IFRX
InflaRx N.V. KLRS
Kalaris Therapeutics Inc CNTB
Connect Biopharma Holdings Limited
Performance
| Periode | MGX | DTIL | ATYR | ADVM | ARTV | STRO | QNCX | IFRX | KLRS | CNTB |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 16.32 % | -8.09 % | -86.51 % | 76.52 % | 119.55 % | 13.34 % | 172.46 % | 33.33 % | 220.97 % | 139.82 % |
| YTD | -55.80 % | 1.71 % | -81.10 % | -9.17 % | -55.52 % | -48.26 % | 100.00 % | -58.40 % | -6.03 % | 94.21 % |
| 1Y | -46.14 % | 0.63 % | -75.61 % | -17.11 % | -57.36 % | -51.76 % | 96.86 % | -54.98 % | -6.03 % | 115.60 % |
| 3Y | -83.75 % | -86.53 % | -57.28 % | -29.56 % | -63.04 % | -86.32 % | 485.03 % | -51.63 % | -6.03 % | 235.71 % |
| 5Y | -83.75 % | -98.12 % | -57.28 % | -96.46 % | -63.04 % | -95.70 % | -88.04 % | -78.69 % | -6.03 % | -87.29 % |
| 10Y | -83.75 % | -99.09 % | -57.28 % | -95.20 % | -63.04 % | -93.43 % | -88.57 % | -93.07 % | -6.03 % | -87.29 % |
| From the beginning | -83.75 % | -99.09 % | -57.28 % | -98.44 % | -63.04 % | -93.43 % | -88.57 % | -93.07 % | -6.03 % | -87.29 % |